Negative Allosteric Modulation of the µ-Opioid Receptor

DNA-encoded libraries from WuXi AppTec were used in a “steered” screening against either inactive or active μ-opioid receptors in parallel, to find novel negative allosteric modulators of this receptor. The molecule discovered via DEL screening not only shows direct and effective in vitro and in vivo potency, but also helps elucidate the mechanism of negative allosteric modulation of GPCRs. This discovery provides a potential therapeutic solution for conquering the current opioid overdose epidemic. We are honored to be part of this collaboration with our academic partner Brian K. Kobilka, Nobel laureate and Professor at Stanford University. Learn more about this novel research and access bioRxiv by clicking below.

View Now
← Return to Resources

Related Content

WuXi AppTec scientists published a study in the open access archive ChemRxiv describing the discovery of highly selective, novel, heme...


A growing body of in vitro and in vivo evidence has demonstrated that trace amine-associated receptor 1 (TAAR1) could negatively...

← View all Central Nervous System & Pain Resources
× peptide, amino acid

Contact An Expert Today!